08921143 · Active · incorporated 12 years, 6 months ago · Cambridge
Biotech Biotech & Life Sciences Drug Discovery Series B+
A cell engineering company focused on commercializing gene editing and gene modulation applications in life sciences research.
Horizon Discovery is a private limited company registered at Companies House under number 08921143, incorporated on 4 March 2014, with a registered office in Cambridge. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 136 filings for this company, including 5 funding rounds. Its most recent round closed in June 2021, raising £258k.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 5 | Jun 2021 | £258k | £1.18 |
| Round 4 | Apr 2020 | £6.9m | £1.02 |
| Round 3 | Aug 2017 | £106.9m | £2.05 |
| Round 2 | Feb 2017 | £1.5m | £0.6774 |
| Round 1 | Aug 2016 | £1.2m | £1.39 |
Showing the 10 most recent of 136 filings.
See the complete cap table with every shareholder, founder tags, dilution across 26 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.